We are live on
!
Find out more
DHFB
Dixon Hubard Feinour & Brown Portfolio holdings
AUM
$842M
1-Year Est. Return
2.74%
This Fund
S&P 500
This Quarter
Est. Return
+7.47%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$369M
AUM Growth
+$20.9M
(+6%)
Cap. Flow
-$1.4M
Cap. Flow
% of AUM
-0.38%
Top 10 Holdings %
Top 10 Hldgs %
25.11%
Holding
205
New
18
Increased
52
Reduced
73
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Phillips 66
PSX
|
+$6.79M |
| 2 |
Avery Dennison
AVY
|
+$6.43M |
| 3 |
Louisiana-Pacific
LPX
|
+$5.1M |
| 4 |
Intel
INTC
|
+$4.19M |
| 5 |
Zoetis
ZTS
|
+$888K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$6.53M |
| 2 |
CELG
Celgene Corp
CELG
|
+$6.5M |
| 3 |
Labcorp
LH
|
+$5.56M |
| 4 |
HealthEquity
HQY
|
+$5.07M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$805K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 16.72% |
| 2 | Technology | 16.16% |
| 3 | Financials | 13.74% |
| 4 | Healthcare | 12.21% |
| 5 | Communication Services | 7.84% |
Similar funds
BDWM
MCM
TFM
MWM
CP
BWM
FPS
IC
Dixon Hubard Feinour & Brown's Q4 2017 Portfolio in Review
As of Q4 2017, Dixon Hubard Feinour & Brown held 205 positions worth $369M, up 6% from $348M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Dixon Hubard Feinour & Brown's Q4 2017 filing shows 18 new, 52 increased, 73 reduced and 13 closed positions. Its largest new stake was Phillips 66: 71,419 shares worth $7.22M. The largest sale was Amgen, an estimated $6.53M.
By sector, the portfolio is most concentrated in Industrials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
- Dixon Hubard Feinour & Brown's largest Q4 2017 buy was Phillips 66: 71,419 shares worth $7.22M.
- Dixon Hubard Feinour & Brown added most to Intel in Q4 2017, an estimated $4.19M increase.
- Dixon Hubard Feinour & Brown's biggest Q4 2017 reduction was Alphabet (Google) Class C, cutting an estimated $805K.
- Dixon Hubard Feinour & Brown fully exited Amgen in Q4 2017, selling an estimated $6.53M.
- Dixon Hubard Feinour & Brown's ten largest holdings make up 25% of its $369M portfolio in Q4 2017.
- Dixon Hubard Feinour & Brown opened 18 new positions and closed 13 in Q4 2017.
- Dixon Hubard Feinour & Brown's portfolio value rose 6% quarter-over-quarter to $369M.
Based on Dixon Hubard Feinour & Brown's 13F filing for Q4 2017, filed 20 Feb 2018.